KPF
MNTA

K2 Principal Fund’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

K2 Principal Fund’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,500
Closed -$656K – 443
2020
Q3 		$656K Buy
+12,500
New +$517K 0.1% 180

K2 Principal Fund's MNTA Position: Q4 2020 in Review

K2 Principal Fund sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 12,500 shares — an estimated $656K sold.

K2 Principal Fund first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $656K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • K2 Principal Fund reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • K2 Principal Fund sold 12,500 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $656K.
  • K2 Principal Fund first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • K2 Principal Fund's Momenta Pharmaceuticals, Inc. position peaked at $656K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on K2 Principal Fund's 13F filing for Q4 2020, filed 12 Feb 2021.